These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6545595)

  • 1. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Echoscopic diagnosis of the heterozygote carrier state in Duchenne's muscular dystrophy].
    Krasil'nikov VV; Lazebnik TA; Prokof'ev GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):18-9. PubMed ID: 3066080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study between CPK, LDH and their isoenzymes in the detection of carriers of Duchenne's type muscular dystrophy].
    Castro-Gago M; Rodríguez-Segade S; Paz M; Novo I; Pombo M; Tojo R
    An Esp Pediatr; 1985 Sep; 23(3):170-4. PubMed ID: 4073685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of determining lactate dehydrogenase in the blood in progressive muscular dystrophy of the Duchenne type and in detection of the carrier state of this disease].
    Niebrój-Dobosz I
    Neurol Neurochir Pol; 1985; 19(3):227-30. PubMed ID: 4047301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the serum biochemistry in carrier detection of Duchenne muscular dystrophy].
    Xie B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):165-8, 189. PubMed ID: 1889329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of young female carriers of Duchenne muscular dystrophy].
    Alvarez Leal MA; Morales-Aguilera A
    Arch Invest Med (Mex); 1990; 21(3):269-72. PubMed ID: 2131776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    Darras BT; Harper JF; Francke U
    N Engl J Med; 1987 Apr; 316(16):985-92. PubMed ID: 3561454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discriminant analysis of methods for detecting the heterozygote carrier state for the Duchenne muscular dystrophy gene].
    Khrennikov VIu; Sitnikov VF; Deev AI; Svintsitskiĭ IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):14-8. PubMed ID: 3223151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Female transmitters of Duchenne's myopathy: detection by quantitative ultrasonography combined with blood creatine kinase].
    Schapira G; Laugier P; Rochette J; Berger G; Katz P; Perrin J
    C R Acad Sci III; 1986; 303(10):377-80. PubMed ID: 3096500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne's muscular dystrophy: carrier detection by muscle ultrasound.
    Rott HD; Mulz D
    J Genet Hum; 1983 Mar; 31(1):63-5. PubMed ID: 6619807
    [No Abstract]   [Full Text] [Related]  

  • 20. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.